Online ISSN: 2515-8260

Keywords : Fetomaternal outcome

Fetomaternal Outcome in Placenta Previa Cross Sectional Study in Teaching Hospital: An Original Research

Dr. Sujata Singh; Dr. Subhasri Mishra; Dr. Aswini Viswanadh

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 11, Pages 6482-6491

Introduction: Placenta previa describes a placenta that is implanted in the lower uterine segment, either over or very near the internal cervical os. Placenta previa is a major cause of maternal morbidity and mortality because of the associated massive antepartum and intrapartum hemorrhage. The maternal and neonatal complications associated with placenta previa are very high. The aims and objectives of the study are to know the maternal and foetal outcome in cases of placenta previa in a tertiary hospital. Material & Methods: This is a cross sectional study of 100 patients admitted during the study period of June 2019 – June 2020. The present study was undertaken to evaluate the various types of placenta previa and its feto-maternal outcome Out of 100 patients, majority of cases belongs to 26-30 years (56%) with highest incidence being in multigravidas. In the present study, there were 55 were male babies & 45 were female babies. Among the 100 cases, 84 were live born babies,13 were intrauterine death,3 were stillborn. Results: Type 3 placenta previa (46%) was the most common type of placenta previa in the present study, out of which 95 (95%) cases were managed actively by Emergency LSCS, Most of the patients, i.e,39 % were at the gestational age of 28- 34 weeks with most common type of placenta previa being Type 4. Malpresentations were common, most common being Breech (13 %). Out of 100 case,47 cases (47%) were belonging to scarred uterus category where type 3 placenta (48.9%) was the most common type of placenta previa & 5 cases (10.6%) had abnormal placentation in the form of placenta accrete (8.5%) placenta percreta (2.1%) Conclusion: Primary prevention in the form of reduction in the rate of primigravida caesarean section must be done in order to prevent likelihood of placenta previa in scarred uterus and its associated morbidity.